Culanag, Helen B.

HRN: 02-90-61  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/13/2026
CEFTRIAXONE 1G (VIAL)
03/13/2026
03/20/2026
IV
2f
OD
CAP-MR; UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary TractPneumonia    Compliance to guidelines: